questionsmedicales.fr
Facteurs biologiques
Facteurs de la coagulation sanguine
Inhibiteurs d'activateurs du plasminogène
Inhibiteurs d'activateurs du plasminogène : Questions médicales fréquentes
Termes MeSH sélectionnés :
Personnel Staffing and Scheduling
Diagnostic
5
Thrombose
Échographie
Tests sanguins
Plasminogène
Tests de laboratoire
Activateurs
Embolie pulmonaire
Essoufflement
Douleur thoracique
Saignement
Antécédents médicaux
Tests de coagulation
Thrombose veineuse profonde
Échographie Doppler
Diagnostic
Symptômes
5
Thrombose
Douleur
Gonflement
Angine
Douleur thoracique
Irradiation
Embolie cérébrale
Troubles de la parole
Confusion
Hémorragie interne
Douleur abdominale
Pâleur
Thrombose artérielle
Douleur intense
Perte de pouls
Prévention
5
Prévention
Thromboses
Exercice
Voyages longs
Hydratation
Bas de compression
Risque post-chirurgical
Anticoagulants
Compression
Alimentation
Vitamine K
Anticoagulants
Tabagisme
Thrombose
Agrégation plaquettaire
Traitements
5
Thrombose
Anticoagulants
Thrombolytiques
Inhibiteurs d'activateurs
Plasminogène
Caillots sanguins
Thrombolytiques
Thrombose aiguë
Dissolution des caillots
Anticoagulants
Saignements
Interactions médicamenteuses
Surveillance
Tests sanguins
Coagulation
Complications
5
Complications
Embolie pulmonaire
Insuffisance veineuse
Hémorragie
Anticoagulants
Surveillance
Embolie
Lésions organiques
Douleurs thoraciques
Thrombose
Douleurs chroniques
Problèmes circulatoires
Prévention
Rééducation
Suivi médical
Facteurs de risque
5
Facteurs de risque
Obésité
Antécédents familiaux
Âge
Thrombose
Circulation sanguine
Génétique
Troubles de la coagulation
Thrombose
Contraceptifs
Thrombose
Tabagisme
Hypertension
Vaisseaux sanguins
Thrombose
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs d'activateurs du plasminogène : Questions médicales les plus fréquentes",
"headline": "Inhibiteurs d'activateurs du plasminogène : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Inhibiteurs d'activateurs du plasminogène : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-30",
"dateModified": "2025-03-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Inhibiteurs d'activateurs du plasminogène"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Facteurs de la coagulation sanguine",
"url": "https://questionsmedicales.fr/mesh/D001779",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs de la coagulation sanguine",
"code": {
"@type": "MedicalCode",
"code": "D001779",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.119"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Inhibiteur-1 d'activateur du plasminogène",
"alternateName": "Plasminogen Activator Inhibitor 1",
"url": "https://questionsmedicales.fr/mesh/D017395",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteur-1 d'activateur du plasminogène",
"code": {
"@type": "MedicalCode",
"code": "D017395",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.119.832.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Inhibiteur-2 d'activateur du plasminogène",
"alternateName": "Plasminogen Activator Inhibitor 2",
"url": "https://questionsmedicales.fr/mesh/D017396",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteur-2 d'activateur du plasminogène",
"code": {
"@type": "MedicalCode",
"code": "D017396",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.119.832.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs d'activateurs du plasminogène",
"alternateName": "Plasminogen Inactivators",
"code": {
"@type": "MedicalCode",
"code": "D015849",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Robert J Parmer",
"url": "https://questionsmedicales.fr/author/Robert%20J%20Parmer",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Veterans Administration San Diego Healthcare System, University of California, San Diego, San Diego, CA, United States."
}
},
{
"@type": "Person",
"name": "Lindsey A Miles",
"url": "https://questionsmedicales.fr/author/Lindsey%20A%20Miles",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, United States."
}
},
{
"@type": "Person",
"name": "Nagyung Baik",
"url": "https://questionsmedicales.fr/author/Nagyung%20Baik",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, United States."
}
},
{
"@type": "Person",
"name": "Beate Heissig",
"url": "https://questionsmedicales.fr/author/Beate%20Heissig",
"affiliation": {
"@type": "Organization",
"name": "Immunological Diagnosis, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan."
}
},
{
"@type": "Person",
"name": "Koichi Hattori",
"url": "https://questionsmedicales.fr/author/Koichi%20Hattori",
"affiliation": {
"@type": "Organization",
"name": "Center for Genomic & Regenerative Medicine, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Nursing Personnel Workload and Staffing Need for Rural Hospitals of Darjeeling District, India: Assessment by Application of Workload Indicators of Staffing Need Tool (World Health Organization).",
"datePublished": "2023-12-29",
"url": "https://questionsmedicales.fr/article/38934835",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/ijph.ijph_1678_22"
}
},
{
"@type": "ScholarlyArticle",
"name": "New Dimensions of Staffing Patterns in Nursing Homes and Nursing Home Quality: Comparing Staffing Instability to Staffing Turnover.",
"datePublished": "2023-05-26",
"url": "https://questionsmedicales.fr/article/37247823",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jamda.2023.04.009"
}
},
{
"@type": "ScholarlyArticle",
"name": "Staffing Shortages, Staffing Hours, and Resident Deaths in US Nursing Homes During the COVID-19 Pandemic.",
"datePublished": "2023-05-08",
"url": "https://questionsmedicales.fr/article/37253431",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jamda.2023.04.020"
}
},
{
"@type": "ScholarlyArticle",
"name": "Determining a risk management staffing model.",
"datePublished": "2022-06-29",
"url": "https://questionsmedicales.fr/article/35768898",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jhrm.21513"
}
},
{
"@type": "ScholarlyArticle",
"name": "Team Nursing Models as a Staffing Solution.",
"datePublished": "2024-08-22",
"url": "https://questionsmedicales.fr/article/39185968",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/01.NAJ.0001050756.36743.14"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Facteurs de la coagulation sanguine",
"item": "https://questionsmedicales.fr/mesh/D001779"
},
{
"@type": "ListItem",
"position": 4,
"name": "Inhibiteurs d'activateurs du plasminogène",
"item": "https://questionsmedicales.fr/mesh/D015849"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Inhibiteurs d'activateurs du plasminogène - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Inhibiteurs d'activateurs du plasminogène",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Inhibiteurs d'activateurs du plasminogène",
"description": "Comment diagnostiquer une thrombose ?\nQuels tests pour évaluer l'activité plasminogène ?\nQuels signes indiquent une embolie pulmonaire ?\nComment évaluer le risque de saignement ?\nQuels examens pour une thrombose veineuse profonde ?",
"url": "https://questionsmedicales.fr/mesh/D015849?mesh_terms=Personnel+Staffing+and+Scheduling#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Inhibiteurs d'activateurs du plasminogène",
"description": "Quels sont les symptômes d'une thrombose ?\nComment reconnaître une crise d'angine ?\nQuels signes d'une embolie cérébrale ?\nQuels symptômes d'une hémorragie interne ?\nComment se manifeste une thrombose artérielle ?",
"url": "https://questionsmedicales.fr/mesh/D015849?mesh_terms=Personnel+Staffing+and+Scheduling#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Inhibiteurs d'activateurs du plasminogène",
"description": "Comment prévenir les thromboses ?\nQuels conseils pour les voyages longs ?\nComment réduire le risque post-chirurgical ?\nQuels aliments éviter pour prévenir les caillots ?\nComment le tabagisme influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D015849?mesh_terms=Personnel+Staffing+and+Scheduling#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Inhibiteurs d'activateurs du plasminogène",
"description": "Quels traitements pour une thrombose ?\nComment agissent les inhibiteurs d'activateurs ?\nQuand utiliser des thrombolytiques ?\nQuels sont les effets secondaires des anticoagulants ?\nComment surveiller l'efficacité du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D015849?mesh_terms=Personnel+Staffing+and+Scheduling#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Inhibiteurs d'activateurs du plasminogène",
"description": "Quelles sont les complications d'une thrombose ?\nQuels risques d'hémorragie avec les traitements ?\nComment une embolie peut-elle affecter la santé ?\nQuels effets à long terme d'une thrombose ?\nComment prévenir les complications post-thrombose ?",
"url": "https://questionsmedicales.fr/mesh/D015849?mesh_terms=Personnel+Staffing+and+Scheduling#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Inhibiteurs d'activateurs du plasminogène",
"description": "Quels sont les facteurs de risque de thrombose ?\nComment l'âge influence-t-il le risque ?\nQuel rôle joue la génétique dans la thrombose ?\nComment les contraceptifs influencent-ils le risque ?\nQuel impact a l'hypertension sur le risque ?",
"url": "https://questionsmedicales.fr/mesh/D015849?mesh_terms=Personnel+Staffing+and+Scheduling#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une thrombose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic de thrombose se fait par échographie, tests sanguins et évaluation clinique."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'activité plasminogène ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme le dosage du plasminogène et l'activité des activateurs sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une embolie pulmonaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent douleur thoracique, essoufflement et toux avec sang."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque de saignement ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par l'historique médical, les antécédents de saignement et des tests."
}
},
{
"@type": "Question",
"name": "Quels examens pour une thrombose veineuse profonde ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie Doppler est l'examen de choix pour diagnostiquer une TVP."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une thrombose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, gonflement et rougeur dans la zone affectée."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une crise d'angine ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une crise d'angine se manifeste par une douleur thoracique, souvent irradiant vers le bras."
}
},
{
"@type": "Question",
"name": "Quels signes d'une embolie cérébrale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des troubles de la parole, faiblesse d'un côté et confusion."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une hémorragie interne ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure douleur abdominale, faiblesse et pâleur."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une thrombose artérielle ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par une douleur intense, une pâleur et une perte de pouls dans le membre."
}
},
{
"@type": "Question",
"name": "Comment prévenir les thromboses ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'exercice régulier, l'hydratation et l'évitement de la sédentarité."
}
},
{
"@type": "Question",
"name": "Quels conseils pour les voyages longs ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de se lever régulièrement, s'hydrater et porter des bas de compression."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque post-chirurgical ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation d'anticoagulants et de dispositifs de compression aide à réduire le risque."
}
},
{
"@type": "Question",
"name": "Quels aliments éviter pour prévenir les caillots ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les aliments riches en vitamine K, qui peuvent interférer avec les anticoagulants."
}
},
{
"@type": "Question",
"name": "Comment le tabagisme influence-t-il le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme augmente le risque de thrombose en favorisant l'agrégation plaquettaire."
}
},
{
"@type": "Question",
"name": "Quels traitements pour une thrombose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les anticoagulants, les thrombolytiques et la compression."
}
},
{
"@type": "Question",
"name": "Comment agissent les inhibiteurs d'activateurs ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils bloquent l'activation du plasminogène, réduisant la dégradation des caillots."
}
},
{
"@type": "Question",
"name": "Quand utiliser des thrombolytiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés en cas de thrombose aiguë pour dissoudre rapidement les caillots."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des anticoagulants ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent saignements, ecchymoses et interactions médicamenteuses."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance se fait par des tests sanguins réguliers pour évaluer la coagulation."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications d'une thrombose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'embolie pulmonaire, l'insuffisance veineuse et les ulcères."
}
},
{
"@type": "Question",
"name": "Quels risques d'hémorragie avec les traitements ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements anticoagulants augmentent le risque d'hémorragie, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Comment une embolie peut-elle affecter la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une embolie peut entraîner des lésions organiques, des douleurs thoraciques et des décès."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme d'une thrombose ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme peuvent inclure des douleurs chroniques et des problèmes circulatoires."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications post-thrombose ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La rééducation, l'exercice et le suivi médical régulier aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de thrombose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, le tabagisme, l'immobilisation et les antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de thrombose augmente avec l'âge en raison de la diminution de la circulation sanguine."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la génétique dans la thrombose ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mutations génétiques peuvent prédisposer à des troubles de la coagulation et à la thrombose."
}
},
{
"@type": "Question",
"name": "Comment les contraceptifs influencent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les contraceptifs hormonaux peuvent augmenter le risque de thrombose, surtout chez les fumeuses."
}
},
{
"@type": "Question",
"name": "Quel impact a l'hypertension sur le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertension peut endommager les vaisseaux sanguins, augmentant le risque de thrombose."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 27/03/2025
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
Department of Medicine, Veterans Administration San Diego Healthcare System, University of California, San Diego, San Diego, CA, United States.
6 publications dans cette catégorie
Affiliations :
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, United States.
4 publications dans cette catégorie
Affiliations :
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, United States.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
4 publications dans cette catégorie
Affiliations :
Immunological Diagnosis, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
4 publications dans cette catégorie
Affiliations :
Center for Genomic & Regenerative Medicine, Juntendo University, School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
3 publications dans cette catégorie
Affiliations :
Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana, USA.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
3 publications dans cette catégorie
Affiliations :
An-Najah Center for Cancer and Stem Cell Research, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus P.O. Box 7, Palestine.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
3 publications dans cette catégorie
Affiliations :
Department of Hematology, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Electronic address: radius@ims.u-tokyo.ac.jp.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, United States.
Center for Drug Research and Development, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, United States.
Center for Drug Research and Development, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Department of Clinical and Toxicological Analyses, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Biochemistry and Biophysics, Umeå University, 90187 Umeå, Sweden.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Biochemistry and Biophysics, Umeå University, 90187 Umeå, Sweden.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Biochemistry and Biophysics, Umeå University, 90187 Umeå, Sweden.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Biochemistry and Biophysics, Umeå University, 90187 Umeå, Sweden.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana, USA.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Prometic Bioproduction, Laval, Quebec, Canada.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Kedrion S.p.A, Castelvecchio Pascoli, Barga (LU), Italy.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
W. M. Keck Center for Transgene Research, Notre Dame, IN, United States.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
W. M. Keck Center for Transgene Research, Notre Dame, IN, United States.
Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN, United States.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi, Chiba 279-0021, Japan.
Publications dans "Inhibiteurs d'activateurs du plasminogène" :
The Workload Indicators of Staffing Need (WISN) human resource planning and management tool developed by Shipp (1998) and popularized by the World Health Organization gives health managers a way to an...
This study aimed to assess the current workload and staffing need of staff nurses for rural hospitals in Darjeeling district, West Bengal....
Primary data were collected by interviews with nursing personnel using a semi-structured interview schedule. Secondary data were obtained from available records at the rural hospitals. Workload compon...
WISN findings highlighted varying degrees of health worker shortages and inequities in their distribution at different health facilities. WISN ratio indicated that the work pressure of health staff wa...
WISN method can help policy-makers in optimizing utilization of existing human resources. There is a need to adopt flexible health workforce planning and recruitment policy to manage the patient load ...
This study examines how measures of staffing-turnover and instability-are associated with one another and how they independently contribute to quality of care in nursing homes....
Cross-sectional analysis of 2021-2022 administrative data. Data included the Payroll Based Journal for daily staffing information, merged with Nursing Home Care Compare (NHCC) data for nursing home ch...
A total of 11,840 nursing homes nationally reporting data on daily staffing and staffing turnover....
We explored correlations between measures of staffing and estimated facility-level regression models with robust standard errors. The dependent variables were indicators of nursing home quality includ...
For the 11,840 nursing homes in the study, there was a weak positive correlation between turnover and instability, with some overlap between nursing homes with high instability and high turnover. Regr...
Instability and turnover in total nursing home staffing independently contribute to nursing home quality. This suggests that adding measures of staffing instability to the existing measures of average...
Staffing shortages at nursing homes during the COVID-19 pandemic may have impacted care providers' staffing hours and affected residents' care and outcomes. This study examines the association of staf...
This study measured staffing hours per resident using payroll data and measured weekly resident deaths and staffing shortages using the Centers for Disease Control and Prevention's National Healthcare...
15,212 nursing homes....
The primary outcomes included staffing hours per resident of registered nurses (RNs), licensed practical nurses (LPNs), and certified nursing assistants (CNAs) and weekly total deaths per 100 resident...
Between May 31, 2020, and May 15, 2022, 18.4% to 33.3% of nursing homes reported staffing shortages during any week. Staffing shortages were associated with lower staffing hours per resident with a 0....
Our results showed that self-reported staffing shortages were associated with a statistically significant decrease in staffing hours and with a statistically significant increase in resident deaths. T...
Health care organizations have struggled to establish par levels of risk management personnel needed to effectively accomplish risk management functions. This study set out to determine whether a par ...
A new study questions their safety and cost-effectiveness....
To identify interprofessional staffing pattern clusters used in U.S. ICUs....
Latent class analysis....
Adult U.S. ICUs....
None....
None....
We used data from a staffing survey that queried respondents (...
We identified three clusters as optimal. Most ICUs (54.2%) were in cluster 1 ("higher overall staffing") characterized by a higher likelihood of good provider coverage (both intensivist [onsite 24 hr/...
More than half of U.S. ICUs had higher staffing overall. Others tended to have either higher provider presence and nursing leadership or higher bedside nursing support, but not both....
Scheduling flexibility and predictability to the end of a clinical workday are strategies aimed at addressing physician burnout. A voluntary relief shift was created to increase the pool of anesthesio...
Repeatedly solving nurse scheduling problems is one of the most difficult and time-consuming tasks for nurse managers. Although software solutions exist to solve nurse scheduling problems automaticall...
Health centers are vital primary care safety nets for underserved populations, but optimal clinician staffing associated with quality care is unclear. Understanding the association of clinician staffi...
To describe the association of clinician staffing models and ratios with quality-of-care metrics in health centers....
This cross-sectional study of US health centers used data from the 2022 Health Resources and Services Administration Uniform Data System (UDS)....
Clinician staffing ratios, expressed as the fraction of full-time equivalents (FTEs) per 1000 visits of physicians, advanced practice registered nurses (APRNs), and physician associates (PAs) to total...
Percentage of eligible patients receiving the corresponding service or outcome for 14 individual clinical quality metrics collected by the UDS, including infant immunizations; screening for cancer, de...
This analysis of 791 health centers serving 16 114 842 patients (56.6% female) identified 5 clinician staffing models: balanced (similar FTEs of physicians, APRNs, and PAs; 152 [19.2%] of health cente...
In this cross-sectional study of health centers, physician FTE ratio was associated with higher performance in cancer screening, infant vaccinations, and HIV testing; APRN FTE ratio was associated wit...
Ambulatory staffing to workload based on visit volume in an outpatient setting is an elusive formula, and the literature describing such processes is limited. One health system tasked a multidisciplin...